Visacor

Nchi: Nyuzilandi

Lugha: Kiingereza

Chanzo: Medsafe (Medicines Safety Authority)

Viambatanisho vya kazi:

Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin

Inapatikana kutoka:

AstraZeneca Limited

INN (Jina la Kimataifa):

Rosuvastatin calcium 10.4 mg (= 10 mg rosuvastatin)

Kipimo:

10 mg

Dawa fomu:

Film coated tablet

Tungo:

Active: Rosuvastatin calcium 10.4mg equivalent to 10 mg rosuvastatin Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Vitengo katika mfuko:

Blister pack, Al/Al foil, 7 tablets

Darasa:

Prescription

Dawa ya aina:

Prescription

Viwandani na:

IPR Pharmaceuticals Inc

Matibabu dalili:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Bidhaa muhtasari:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 7 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Idhini ya tarehe:

2009-07-31